| abstract |
A stable vaccine composition is disclosed which includes at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent water; and a foaming-reducing effective amount of a foam controlling foaming-reducing agent which is a sugar alcohol which is mannitol, sorbitol, and/or xylitol. A process for reducing foaming when the composition is mixed with water is also disclosed. |